Patents by Inventor J. Edwin Seegmiller

J. Edwin Seegmiller has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Diagnosing an animal for pyrophosphate gout, osteoporosis, or osteoarthritis by assaying intracellular pyrophosphate content in peripheral blood cells
    Patent number: 6521615
    Abstract: This invention provides a method of treating an animal with pyrophosphate gout or osteoarthritis comprising administering an effective amount of a calcium antagonist, thereby reducing calcium pyrophosphate crystal deposition in the animal.
    Type: Grant
    Filed: January 4, 2001
    Date of Patent: February 18, 2003
    Assignee: The Regents of the University of California
    Inventor: J. Edwin Seegmiller
  • New use for an established class of drugs
    Publication number: 20010009910
    Abstract: This invention provides a method of treating an animal with pyrophosphate gout or osteoarthritis comprising administering an effective amount of a calcium antagonist, thereby reducing calcium pyrophosphate crystal deposition in the animal.
    Type: Application
    Filed: January 4, 2001
    Publication date: July 26, 2001
    Applicant: The Regents of the University of California
    Inventor: J. Edwin Seegmiller
  • Reducing pyrophosphate deposition with calcium antagonists
    Patent number: 6221861
    Abstract: This invention provides a method of treating an animal with pyrophosphate gout or osteoarthritis comprising administering an effective amount of a calcium antagonist, thereby reducing calcium pyrophosphate crystal deposition in the animal.
    Type: Grant
    Filed: July 9, 1999
    Date of Patent: April 24, 2001
    Assignee: The Regents of the University of California
    Inventor: J. Edwin Seegmiller
  • Immunoglobulin-secreting human hybridomas from a cultured human lymphoblastoid cell line
    Patent number: 4451570
    Abstract: Novel human lymphoblastoid cells and hybridomas derived therefrom are provided. The cells are a HGPRT negative human B-cell line. The cells are readily fusible with lymphoid cells to produce hybridomas which secrete human monoclonal antibodies.
    Type: Grant
    Filed: March 26, 1981
    Date of Patent: May 29, 1984
    Assignee: The Regents of the University of California
    Inventors: Ivor Royston, Harold Handley, J. Edwin Seegmiller, Linda F. Thompson